Endocrinology Hormones
Articles & Whitepapers
-
Do Peptide Drugs Need Acylation Blocking at Nα?
The formation of 2,5-diketopiperazine (DKP) with a bicyclic structure is one of the most detrimental side reactions and degradation pathways affecting peptide synthesis. Despite its crucial role as a versatile building block in drug discovery, the formation of DKP reactions is highly undesirable in the production of peptide drugs. DKP formation can occur during the process of peptide drug ...
-
Peptides for Osteoporosis Research
Introduction to OsteoporosisOsteoporosis is a systemic multi-causal skeletal disease that is prone to fractures due to changes in systemic bone mass and microstructure of bone tissue, resulting in ...
News
-
ctDNA-guided Adaptive Therapy Escalation in ER+ MBC: A Phase 1b Study with Letrozole, Palbociclib and Onapristone ER
Extended release Onapristone (Onapristone ER) is a progesterone receptor (PR) antagonist that inhibits hormone-mediated PR activation and stabilizes PR association with compressors, resulting in an antineoplastic effect when applied alone or in ...
CD Formulation Empowers High-volume Manufacturing of Microspheres
Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients
CD Formulation Introduces Comprehensive Range of Microsphere and Microneedle Solutions for Pharma and Biotech Applications
FPI Explores the Future of Cognitive Healthcare at the 87th China International Medical Equipment Fair (CMEF)
Equipment & Solutions
-
Showcase
Injection
Used to treat breast cancer, non-small-cell lung cancer, prostate cancer, ovarian cancer, head and neck cancer, and esophageal cancer.